Why the study?
Warfarin is the only approved anticoagulant after mechanical valve replacement, but it is a well-described risk factor for calciphylaxis among patients with end-stage kidney disease.
Warfarin initiation after mechanical valve replacement in patients with end-stage kidney disease can trigger rapidly progressive and fatal calciphylaxis.
Answers are grounded in this paper and cite their sources.
Warfarin initiation was associated with fatal calciphylaxis post-mechanical valves in ESKD; hypothesis-generating for safer anticoagulation alternatives.
Warfarin is the only approved anticoagulant after mechanical valve replacement, but it is a well described risk factor for calciphylaxis among patients with end-stage kidney disease. Our patient with end-stage kidney disease rapidly developed calciphylaxis after dual mechanical valve replacement in association with warfarin initiation, posing significant challenges in clinical management and a fatal outcome. (Level of Difficulty: Intermediate.)
No takes yet. Share an insight, caveat, or question.
Nyembo et al. (2022) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: